Eric J Stanbridge

US Patent:

6379907, Apr 30, 2002

Filed:

Dec 15, 1999

Appl. No.:

09/461938

Inventors:

Shu-Yuan Liao - Anaheim CA
Eric J. Stanbridge - Corona del Mar CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 33574

US Classification:

435 723, 435 4, 435 6, 435 71, 435 72, 436 64, 436501, 436503

Abstract:

Determining the presence of cancerous or pre-cancerous cervical lesions from AGUS-diagnosed Pap smear cells by observing the distribution of MN/CA9 antigen expressed on atypical or normal cells and diagnosing (a) significant lesions when MN/CA9 antigen is observed on atypical cells, (b) low grade lesions when MN/CA9 antigen is absent from atypical cells but is present on normal endocervical cells, and (c) a benign condition when MN/CA9 antigen is absent from both atypical cells and normal endocervical cells.

US Patent:

6403327, Jun 11, 2002

Filed:

May 16, 2000

Appl. No.:

09/572756

Inventors:

Shu-Yuan Liao - Anaheim CA
Eric J. Stanbridge - Corona del Mar CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 33574

US Classification:

435 723, 435 71, 435 72, 424 64, 5303871

Abstract:

Determining the presence of cancerous or pre-cancerous cervical lesions from ASCUS-diagnosed Pap smear cells by observing the distribution of MN/CA9 antigen expressed on atypical or normal cells and diagnosing (a) significant lesions when MN/CA9 antigen is observed on atypical cells, (b) low grade lesions when MN/CA9 antigen is absent from atypical cells but is present on normal endocervical cells, and (c) a benign condition when MN/CA9 antigen is absent from both atypical cells and normal endocervical cells.

US Patent:

7759119, Jul 20, 2010

Filed:

Apr 9, 2007

Appl. No.:

11/733053

Inventors:

Nancy Allbritton - Irvine CA, US
Christopher E. Sims - Irvine CA, US
Yuli Wang - Irvine CA, US
Mark Bachman - Irvine CA, US
Eric Stanbridge - Corona Del Mar CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

C12N 15/00
C12N 5/02
C12N 5/00
C12N 15/01
C12N 1/02

US Classification:

435325, 435440, 4352523, 4351739, 435174

Abstract:

A plate manufactured to enable samples of cells, micro-organisms, proteins, DNA, biomolecules and other biological media to be positioned at specific locations or sites on the plate for the purpose of performing addressable analyses on the samples. Preferably, some or all of the sites are built from a removable material or as pallets so that a subset of the samples of interest can be readily isolated from the plate for further processing or analysis. The plate can contain structures or chemical treatments that enhance or promote the attachment and/or function of the samples, and that promote or assist in their analyses. Use of the plate advantageously enables the selection and sorting of cells based on dynamic phenomena and the rapid establishment of stable tranfectants.

US Patent:

58517677, Dec 22, 1998

Filed:

Jun 6, 1995

Appl. No.:

8/469600

Inventors:

Eric J. Stanbridge - Corona Del Mar CA
Ulf Gobel - Freiberg, DE

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

C12Q 168
C07H 2104

US Classification:

435 6

Abstract:

Biological probes useful for detecting mycoplasmas or prokaryotes in general, or specific mycoplasma and eubacterial species are derived from the ribosomal RNA gene by selecting particular nucleotide sequences common to the class of organisms being detected.

US Patent:

62455095, Jun 12, 2001

Filed:

Sep 14, 1998

Appl. No.:

9/152375

Inventors:

Eric J. Stanbridge - Corona del Mar CA
Ulf B. Gobel - Berlin, DE

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

C12Q 108
C12N 1511
C07H 2104

US Classification:

435 6

Abstract:

Biological probes useful for detecting mycoplasmas or prokaryotes in general, or specific mycoplasma and eubacterial species are derived from the ribosomal RNA gene by selecting particular nucleotide sequences common to the class of organisms being detected.